|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:The_Medicines_Company
gptkb:Alcon
gptkb:AveXis
gptkb:Chiron_Corporation
gptkb:Endocyte
|
|
gptkbp:CEO
|
gptkb:Vas_Narasimhan
|
|
gptkbp:chairman
|
gptkb:Joerg_Reinhardt
|
|
gptkbp:country
|
gptkb:Switzerland
|
|
gptkbp:divested
|
gptkb:Sandoz_(2023)
|
|
gptkbp:founded
|
1996
|
|
gptkbp:foundedBy
|
gptkb:Sandoz
gptkb:Ciba-Geigy
|
|
gptkbp:headquartersLocation
|
gptkb:Basel,_Switzerland
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Novartis AG
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:ISIN
|
CH0012005267
|
|
gptkbp:legalForm
|
gptkb:company
|
|
gptkbp:logo
|
Novartis logo.svg
|
|
gptkbp:marketCap
|
$200+ billion (2024)
|
|
gptkbp:memberOf
|
gptkb:International_Federation_of_Pharmaceutical_Manufacturers_&_Associations
gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
|
|
gptkbp:netIncome
|
$7.047 billion (2023)
|
|
gptkbp:notableProduct
|
gptkb:Gleevec
gptkb:Afinitor
gptkb:Cosentyx
gptkb:Diovan
gptkb:Entresto
gptkb:Exforge
gptkb:Exjade
gptkb:Galvus
gptkb:Ilaris
gptkb:Jakavi
gptkb:Kymriah
gptkb:Lucentis
gptkb:Mekinist
gptkb:Promacta
gptkb:Rydapt
gptkb:Sandostatin
gptkb:Tafinlar
gptkb:Tasigna
gptkb:Voltaren
gptkb:Zolgensma
gptkb:Inclisiran
gptkb:Adakveo
gptkb:Beovu
gptkb:Kesimpta
gptkb:Leqvio
gptkb:Mayzent
gptkb:Piqray
gptkb:Scemblix
gptkb:Tabrecta
|
|
gptkbp:numberOfEmployees
|
101703
|
|
gptkbp:numberOfLocations
|
over 140 countries
|
|
gptkbp:officialLanguage
|
gptkb:French
gptkb:German
gptkb:Italian
English
|
|
gptkbp:parentCompany
|
None (independent)
|
|
gptkbp:products
|
Pharmaceutical drugs
Generic drugs
Biosimilars
|
|
gptkbp:revenue
|
$50.545 billion (2023)
|
|
gptkbp:servesArea
|
Worldwide
|
|
gptkbp:stockExchange
|
gptkb:New_York_Stock_Exchange
gptkb:SIX_Swiss_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:NOVN
gptkb:NVS
|
|
gptkbp:subsidiary
|
gptkb:Sandoz_(until_2023)
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.novartis.com/
|
|
gptkbp:bfsParent
|
gptkb:NOVN
|
|
gptkbp:bfsLayer
|
5
|